These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. Giesing DH; Bighley LD; Iles RL J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642 [TBL] [Abstract][Full Text] [Related]
63. [Value of antacids in ulcer therapy. Continuing the tradition or scientific progress?]. Szelenyi I Leber Magen Darm; 1987 Jul; 17(3):150-62. PubMed ID: 3613813 [TBL] [Abstract][Full Text] [Related]
64. [The modern treatment of peptic ulcer disease]. Soffer E; Bar-Meir S Harefuah; 1986 Feb; 110(4):185-7. PubMed ID: 3522377 [No Abstract] [Full Text] [Related]
65. Drug therapy and peptic ulceration. Kelly J Br J Nurs; 1994 Nov 24-Dec 7; 3(21):1129-34. PubMed ID: 7827467 [TBL] [Abstract][Full Text] [Related]
66. Therapies for acid peptic disease. Loogman EA Gastroenterol Nurs; 1991; 13(4):198-201. PubMed ID: 2031943 [TBL] [Abstract][Full Text] [Related]
67. Directives, methods and suggestions for anti-ulcer drug therapy. Varró V Ther Hung; 1985; 33(3):125-31. PubMed ID: 2876535 [No Abstract] [Full Text] [Related]
68. [Effect of hypothiazide on gastric secretion in peptic ulcer]. Orlikov GA; Makena VD Vrach Delo; 1980 Mar; (3):26-8. PubMed ID: 7376605 [No Abstract] [Full Text] [Related]
69. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer]. Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615 [No Abstract] [Full Text] [Related]
70. Present and future treatment of peptic ulcer and potential role of DE-NOL. Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852 [No Abstract] [Full Text] [Related]
72. [Conservative treatment of uncomplicated peptic ulcer by various methods]. Sülle C; Murasko V; Balalükin A; Maljarova L; Lapsina S; Zsuravlev A Orv Hetil; 1985 Mar; 126(13):757-61. PubMed ID: 2859568 [No Abstract] [Full Text] [Related]
73. [Innovations in the medical therapy of gastroduodenal ulcers]. Loly J Rev Med Liege; 1984 May; 39(9):365-7. PubMed ID: 6729308 [No Abstract] [Full Text] [Related]
74. Drugs for treatment of peptic ulcers. Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791 [No Abstract] [Full Text] [Related]
75. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients]. Søndergaard B; Bytzer P Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170 [No Abstract] [Full Text] [Related]
76. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Scheen AJ Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183 [TBL] [Abstract][Full Text] [Related]
77. [Clinical trial of Alcid V in peptic ulcer therapy]. Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375 [No Abstract] [Full Text] [Related]
78. [Mechanism of action of the gastric secretion inhibitor Pirenzepin]. Hammer R; Koss FW Fortschr Med; 1980 Apr; 98(14):(549-54). PubMed ID: 6892811 [No Abstract] [Full Text] [Related]